Mehmed, Berna
Fronius, Maria
Pohl, Tabea
Ackermann, Hanns
Schramm, Charlotte
Spieth, Bettina
Hofmann, Christian
Kohnen, Thomas
Wenner, Yaroslava http://orcid.org/0000-0002-1914-8174
Funding for this research was provided by:
augenstern e. v.
Universitätsklinikum Frankfurt
Article History
Received: 18 June 2021
Revised: 30 August 2021
Accepted: 10 September 2021
First Online: 16 October 2021
Change Date: 21 February 2022
Change Type: Update
Change Details: Open Access funding enabled and organized by Projekt DEAL has been added as funding statement.
Declarations
:
: The study was administered according to the Declaration of Helsinki of the World Medical Association. The Ethics Committees of the Universities of Frankfurt and Tübingen approved the study protocol before initiation.
: Prior to enrolment in the study parents and patients older than 7 years declared their written informed consent and younger patients their assent.
: All the authors approved the final manuscript to be published.
: The authors declare no competing interests.Financial disclosure T. Kohnen: Consultant and Research for Abbott/J&J, Alcon/Novartis, Avedro, Oculentis, Oculus, Presbia, Santen, Schwind, Zeiss. Consultant for Allergan, Bausch & Lomb, Dompé, Geuder, Med Update, Merck, Rayner, Staar, Théa, Tear Lab, Thieme, Ziemer. Research for Avedro, Hoya.